Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Hydroxycarbamide Market 2018, Forecast to 2023

Publisher Name :
Date: 10-Aug-2018
No. of pages: 130

Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.

Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic family of medications. It is believed to work by blocking the making of DNA.

Scope of the Report:

This report focuses on the Hydroxycarbamide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of Hydroxycarbamide includes capsule and tablet, and the proportion of capsule in 2016 is about 63%, and the proportion is in decreasing trend from 2012 to 2016.

Hydroxycarbamide is widely used for sickle cell disease, cancer and other disease. The most proportion of Hydroxycarbamide is used for sickle cell disease, and the proportion in 2016 is 45%.

Asia Pacific is the largest supplier of Hydroxycarbamide, with a production market share nearly 59% in 2016.

Middle East and Africa is the largest consumption place, with a consumption market share nearly 36% in 2016. Following Middle East and Africa, Asia Pacific is the second largest consumption place with the consumption market share of 20%.

Market competition is not intense. Bristol Myers Squibb, Taj Pharma, Beijing Jialin Pharma, Qilu Pharmaceutical, Teva Pharma, Cipla, Zydus Cadila, United Biotech, Par Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Hydroxycarbamide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Bristol Myers Squibb

- Taj Pharma

- Beijing Jialin Pharma

- Qilu Pharmaceutical

- Teva Pharma

- Cipla

- Zydus Cadila

- United Biotech

- Par Pharma

- Khandelwal Laboratories

- Alkem (Cytomed)

- Samarth Pharma

- VHB Life Sciences

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Capsule

- Tablet

Market Segment by Applications, can be divided into

- Sickle Cell Disease

- Cancer

- Other

There are 15 Chapters to deeply display the global Hydroxycarbamide market.

Chapter 1, to describe Hydroxycarbamide Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Hydroxycarbamide, with sales, revenue, and price of Hydroxycarbamide, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Hydroxycarbamide, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Hydroxycarbamide market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Hydroxycarbamide sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Hydroxycarbamide Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Hydroxycarbamide Introduction
1.2 Market Analysis by Type
1.2.1 Capsule
1.2.2 Tablet
1.3 Market Analysis by Applications
1.3.1 Sickle Cell Disease
1.3.2 Cancer
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol Myers Squibb
2.1.1 Business Overview
2.1.1.1 Bristol Myers Squibb Description
2.1.1.2 Bristol Myers Squibb Headquarter, Main Business and Finance Overview
2.1.2 Bristol Myers Squibb Hydroxycarbamide Product Introduction
2.1.2.1 Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
2.1.2.2 Hydroxycarbamide Product Information
2.1.3 Bristol Myers Squibb Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Bristol Myers Squibb Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Bristol Myers Squibb Hydroxycarbamide Market Share in 2017
2.2 Taj Pharma
2.2.1 Business Overview
2.2.1.1 Taj Pharma Description
2.2.1.2 Taj Pharma Headquarter, Main Business and Finance Overview
2.2.2 Taj Pharma Hydroxycarbamide Product Introduction
2.2.2.1 Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
2.2.2.2 Hydroxycarbamide Product Information
2.2.3 Taj Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Taj Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Taj Pharma Hydroxycarbamide Market Share in 2017
2.3 Beijing Jialin Pharma
2.3.1 Business Overview
2.3.1.1 Beijing Jialin Pharma Description
2.3.1.2 Beijing Jialin Pharma Headquarter, Main Business and Finance Overview
2.3.2 Beijing Jialin Pharma Hydroxycarbamide Product Introduction
2.3.2.1 Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
2.3.2.2 Hydroxycarbamide Product Information
2.3.3 Beijing Jialin Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Beijing Jialin Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Beijing Jialin Pharma Hydroxycarbamide Market Share in 2017
2.4 Qilu Pharmaceutical
2.4.1 Business Overview
2.4.1.1 Qilu Pharmaceutical Description
2.4.1.2 Qilu Pharmaceutical Headquarter, Main Business and Finance Overview
2.4.2 Qilu Pharmaceutical Hydroxycarbamide Product Introduction
2.4.2.1 Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
2.4.2.2 Hydroxycarbamide Product Information
2.4.3 Qilu Pharmaceutical Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Qilu Pharmaceutical Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Qilu Pharmaceutical Hydroxycarbamide Market Share in 2017
2.5 Teva Pharma
2.5.1 Business Overview
2.5.1.1 Teva Pharma Description
2.5.1.2 Teva Pharma Headquarter, Main Business and Finance Overview
2.5.2 Teva Pharma Hydroxycarbamide Product Introduction
2.5.2.1 Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
2.5.2.2 Hydroxycarbamide Product Information
2.5.3 Teva Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Teva Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Teva Pharma Hydroxycarbamide Market Share in 2017
2.6 Cipla
2.6.1 Business Overview
2.6.1.1 Cipla Description
2.6.1.2 Cipla Headquarter, Main Business and Finance Overview
2.6.2 Cipla Hydroxycarbamide Product Introduction
2.6.2.1 Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
2.6.2.2 Hydroxycarbamide Product Information
2.6.3 Cipla Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Cipla Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Cipla Hydroxycarbamide Market Share in 2017
2.7 Zydus Cadila
2.7.1 Business Overview
2.7.1.1 Zydus Cadila Description
2.7.1.2 Zydus Cadila Headquarter, Main Business and Finance Overview
2.7.2 Zydus Cadila Hydroxycarbamide Product Introduction
2.7.2.1 Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
2.7.2.2 Hydroxycarbamide Product Information
2.7.3 Zydus Cadila Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Zydus Cadila Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Zydus Cadila Hydroxycarbamide Market Share in 2017
2.8 United Biotech
2.8.1 Business Overview
2.8.1.1 United Biotech Description
2.8.1.2 United Biotech Headquarter, Main Business and Finance Overview
2.8.2 United Biotech Hydroxycarbamide Product Introduction
2.8.2.1 Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
2.8.2.2 Hydroxycarbamide Product Information
2.8.3 United Biotech Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 United Biotech Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global United Biotech Hydroxycarbamide Market Share in 2017
2.9 Par Pharma
2.9.1 Business Overview
2.9.1.1 Par Pharma Description
2.9.1.2 Par Pharma Headquarter, Main Business and Finance Overview
2.9.2 Par Pharma Hydroxycarbamide Product Introduction
2.9.2.1 Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
2.9.2.2 Hydroxycarbamide Product Information
2.9.3 Par Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Par Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Par Pharma Hydroxycarbamide Market Share in 2017
2.10 Khandelwal Laboratories
2.10.1 Business Overview
2.10.1.1 Khandelwal Laboratories Description
2.10.1.2 Khandelwal Laboratories Headquarter, Main Business and Finance Overview
2.10.2 Khandelwal Laboratories Hydroxycarbamide Product Introduction
2.10.2.1 Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
2.10.2.2 Hydroxycarbamide Product Information
2.10.3 Khandelwal Laboratories Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Khandelwal Laboratories Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Khandelwal Laboratories Hydroxycarbamide Market Share in 2017
2.11 Alkem (Cytomed)
2.11.1 Business Overview
2.11.2 Alkem (Cytomed) Hydroxycarbamide Product Introduction
2.11.3 Alkem (Cytomed) Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Samarth Pharma
2.12.1 Business Overview
2.12.2 Samarth Pharma Hydroxycarbamide Product Introduction
2.12.3 Samarth Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 VHB Life Sciences
2.13.1 Business Overview
2.13.2 VHB Life Sciences Hydroxycarbamide Product Introduction
2.13.3 VHB Life Sciences Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hydroxycarbamide Market Competition, by Manufacturer
3.1 Global Hydroxycarbamide Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hydroxycarbamide Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Hydroxycarbamide Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Hydroxycarbamide Manufacturer Market Share in 2017
3.4.2 Top 5 Hydroxycarbamide Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Hydroxycarbamide Market Analysis by Regions
4.1 Global Hydroxycarbamide Sales, Revenue and Market Share by Regions
4.1.1 Global Hydroxycarbamide Sales by Regions (2013-2018)
4.1.2 Global Hydroxycarbamide Revenue by Regions (2013-2018)
4.2 North America Hydroxycarbamide Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Hydroxycarbamide Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hydroxycarbamide Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Hydroxycarbamide Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hydroxycarbamide Sales, Revenue and Growth Rate (2013-2018)
5 North America Hydroxycarbamide by Countries, Type, Application and Manufacturers
5.1 North America Hydroxycarbamide Sales, Revenue and Market Share by Countries
5.1.1 North America Hydroxycarbamide Sales by Countries (2013-2018)
5.1.2 North America Hydroxycarbamide Revenue by Countries (2013-2018)
5.1.3 United States Hydroxycarbamide Sales and Growth Rate (2013-2018)
5.1.4 Canada Hydroxycarbamide Sales and Growth Rate (2013-2018)
5.1.5 Mexico Hydroxycarbamide Sales and Growth Rate (2013-2018)
5.2 North America Hydroxycarbamide Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Hydroxycarbamide Sales by Manufacturers (2016-2017)
5.2.2 North America Hydroxycarbamide Revenue by Manufacturers (2016-2017)
5.3 North America Hydroxycarbamide Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Hydroxycarbamide Sales and Sales Share by Type (2013-2018)
5.3.2 North America Hydroxycarbamide Revenue and Revenue Share by Type (2013-2018)
5.4 North America Hydroxycarbamide Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Hydroxycarbamide Sales and Sales Share by Application (2013-2018)
5.4.2 North America Hydroxycarbamide Revenue and Revenue Share by Application (2013-2018)
6 Europe Hydroxycarbamide by Countries, Type, Application and Manufacturers
6.1 Europe Hydroxycarbamide Sales, Revenue and Market Share by Countries
6.1.1 Europe Hydroxycarbamide Sales by Countries (2013-2018)
6.1.2 Europe Hydroxycarbamide Revenue by Countries (2013-2018)
6.1.3 Germany Hydroxycarbamide Sales and Growth Rate (2013-2018)
6.1.4 UK Hydroxycarbamide Sales and Growth Rate (2013-2018)
6.1.5 France Hydroxycarbamide Sales and Growth Rate (2013-2018)
6.1.6 Russia Hydroxycarbamide Sales and Growth Rate (2013-2018)
6.1.7 Italy Hydroxycarbamide Sales and Growth Rate (2013-2018)
6.2 Europe Hydroxycarbamide Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Hydroxycarbamide Sales by Manufacturers (2016-2017)
6.2.2 Europe Hydroxycarbamide Revenue by Manufacturers (2016-2017)
6.3 Europe Hydroxycarbamide Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Hydroxycarbamide Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Hydroxycarbamide Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Hydroxycarbamide Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Hydroxycarbamide Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Hydroxycarbamide Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Hydroxycarbamide by Countries, Type,

Application and Manufacturers
7.1 Asia-Pacific Hydroxycarbamide Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Hydroxycarbamide Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Hydroxycarbamide Revenue by Countries (2013-2018)
7.1.3 China Hydroxycarbamide Sales and Growth Rate (2013-2018)
7.1.4 Japan Hydroxycarbamide Sales and Growth Rate (2013-2018)
7.1.5 Korea Hydroxycarbamide Sales and Growth Rate (2013-2018)
7.1.6 India Hydroxycarbamide Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Hydroxycarbamide Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Hydroxycarbamide Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Hydroxycarbamide Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Hydroxycarbamide Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Hydroxycarbamide Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Hydroxycarbamide Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Hydroxycarbamide Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Hydroxycarbamide Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Hydroxycarbamide Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Hydroxycarbamide Revenue and Revenue Share by Application (2013-2018)
8 South America Hydroxycarbamide by Countries, Type, Application and Manufacturers
8.1 South America Hydroxycarbamide Sales, Revenue and Market Share by Countries
8.1.1 South America Hydroxycarbamide Sales by Countries (2013-2018)
8.1.2 South America Hydroxycarbamide Revenue by Countries (2013-2018)
8.1.3 Brazil Hydroxycarbamide Sales and Growth Rate (2013-2018)
8.1.4 Argentina Hydroxycarbamide Sales and Growth Rate (2013-2018)
8.1.5 Colombia Hydroxycarbamide Sales and Growth Rate (2013-2018)
8.2 South America Hydroxycarbamide Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Hydroxycarbamide Sales by Manufacturers (2016-2017)
8.2.2 South America Hydroxycarbamide Revenue by Manufacturers (2016-2017)
8.3 South America Hydroxycarbamide Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Hydroxycarbamide Sales and Sales Share by Type (2013-2018)
8.3.2 South America Hydroxycarbamide Revenue and Revenue Share by Type (2013-2018)
8.4 South America Hydroxycarbamide Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Hydroxycarbamide Sales and Sales Share by Application (2013-2018)
8.4.2 South America Hydroxycarbamide Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Hydroxycarbamide by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Hydroxycarbamide Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hydroxycarbamide Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Hydroxycarbamide Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Hydroxycarbamide Sales and Growth Rate (2013-2018)
9.1.4 UAE Hydroxycarbamide Sales and Growth Rate (2013-2018)
9.1.5 Egypt Hydroxycarbamide Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Hydroxycarbamide Sales and Growth Rate (2013-2018)
9.1.7 South Africa Hydroxycarbamide Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Hydroxycarbamide Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Hydroxycarbamide Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Hydroxycarbamide Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Hydroxycarbamide Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Hydroxycarbamide Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Hydroxycarbamide Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Hydroxycarbamide Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Hydroxycarbamide Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Hydroxycarbamide Revenue and Revenue Share by Application (2013-2018)
10 Global Hydroxycarbamide Market Segment by Type
10.1 Global Hydroxycarbamide Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Hydroxycarbamide Sales and Market Share by Type (2013-2018)
10.1.2 Global Hydroxycarbamide Revenue and Market Share by Type (2013-2018)
10.2 Capsule Sales Growth and Price
10.2.1 Global Capsule Sales Growth (2013-2018)
10.2.2 Global Capsule Price (2013-2018)
10.3 Tablet Sales Growth and Price
10.3.1 Global Tablet Sales Growth (2013-2018)
10.3.2 Global Tablet Price (2013-2018)
11 Global Hydroxycarbamide Market Segment by Application
11.1 Global Hydroxycarbamide Sales Market Share by Application (2013-2018)
11.2 Sickle Cell Disease Sales Growth (2013-2018)
11.3 Cancer Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Hydroxycarbamide Market Forecast (2018-2023)
12.1 Global Hydroxycarbamide Sales, Revenue and Growth Rate (2018-2023)
12.2 Hydroxycarbamide Market Forecast by Regions (2018-2023)
12.2.1 North America Hydroxycarbamide Market Forecast (2018-2023)
12.2.2 Europe Hydroxycarbamide Market Forecast (2018-2023)
12.2.3 Asia-Pacific Hydroxycarbamide Market Forecast (2018-2023)
12.2.4 South America Hydroxycarbamide Market Forecast (2018-2023)
12.2.5 Middle East and Africa Hydroxycarbamide Market Forecast (2018-2023)
12.3 Hydroxycarbamide Market Forecast by Type (2018-2023)
12.3.1 Global Hydroxycarbamide Sales Forecast by Type (2018-2023)
12.3.2 Global Hydroxycarbamide Market Share Forecast by Type (2018-2023)
12.4 Hydroxycarbamide Market Forecast by Application (2018-2023)
12.4.1 Global Hydroxycarbamide Sales Forecast by Application (2018-2023)
12.4.2 Global Hydroxycarbamide Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Hydroxycarbamide Picture
Table Product Specifications of Hydroxycarbamide
Figure Global Hydroxycarbamide CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Hydroxycarbamide CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Hydroxycarbamide by Types in 2017
Figure Capsule Picture
Table Major Manufacturers of Capsule
Figure Tablet Picture
Table Major Manufacturers of Tablet
Figure Hydroxycarbamide Sales Market Share by Applications in 2017
Figure Sickle Cell Disease Picture
Figure Cancer Picture
Figure Other Picture
Figure United States Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure France Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure UK Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure China Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure India Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Hydroxycarbamide Revenue (Value) and Growth Rate (2013-2023)
Table Bristol Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol Myers Squibb Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
Table Bristol Myers Squibb Hydroxycarbamide Product
Table Bristol Myers Squibb Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol Myers Squibb Hydroxycarbamide Sales Market Share in 2017
Figure Global Bristol Myers Squibb Hydroxycarbamide Revenue Market Share in 2017
Table Taj Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Taj Pharma Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
Table Taj Pharma Hydroxycarbamide Product
Table Taj Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Taj Pharma Hydroxycarbamide Sales Market Share in 2017
Figure Global Taj Pharma Hydroxycarbamide Revenue Market Share in 2017
Table Beijing Jialin Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Beijing Jialin Pharma Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
Table Beijing Jialin Pharma Hydroxycarbamide Product
Table Beijing Jialin Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Beijing Jialin Pharma Hydroxycarbamide Sales Market Share in 2017
Figure Global Beijing Jialin Pharma Hydroxycarbamide Revenue Market Share in 2017
Table Qilu Pharmaceutical Headquarter, Established, Main Business and Finance Overview (2017)
Table Qilu Pharmaceutical Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
Table Qilu Pharmaceutical Hydroxycarbamide Product
Table Qilu Pharmaceutical Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Qilu Pharmaceutical Hydroxycarbamide Sales Market Share in 2017
Figure Global Qilu Pharmaceutical Hydroxycarbamide Revenue Market Share in 2017
Table Teva Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Teva Pharma Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
Table Teva Pharma Hydroxycarbamide Product
Table Teva Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teva Pharma Hydroxycarbamide Sales Market Share in 2017
Figure Global Teva Pharma Hydroxycarbamide Revenue Market Share in 2017
Table Cipla Headquarter, Established, Main Business and Finance Overview (2017)
Table Cipla Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
Table Cipla Hydroxycarbamide Product
Table Cipla Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Cipla Hydroxycarbamide Sales Market Share in 2017
Figure Global Cipla Hydroxycarbamide Revenue Market Share in 2017
Table Zydus Cadila Headquarter, Established, Main Business and Finance Overview (2017)
Table Zydus Cadila Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
Table Zydus Cadila Hydroxycarbamide Product
Table Zydus Cadila Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Zydus Cadila Hydroxycarbamide Sales Market Share in 2017
Figure Global Zydus Cadila Hydroxycarbamide Revenue Market Share in 2017
Table United Biotech Headquarter, Established, Main Business and Finance Overview (2017)
Table United Biotech Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
Table United Biotech Hydroxycarbamide Product
Table United Biotech Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global United Biotech Hydroxycarbamide Sales Market Share in 2017
Figure Global United Biotech Hydroxycarbamide Revenue Market Share in 2017
Table Par Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Par Pharma Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
Table Par Pharma Hydroxycarbamide Product
Table Par Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Par Pharma Hydroxycarbamide Sales Market Share in 2017
Figure Global Par Pharma Hydroxycarbamide Revenue Market Share in 2017
Table Khandelwal Laboratories Headquarter, Established, Main Business and Finance Overview (2017)
Table Khandelwal Laboratories Hydroxycarbamide Production Bases, Sales Regions and Major Competitors
Table Khandelwal Laboratories Hydroxycarbamide Product
Table Khandelwal Laboratories Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Khandelwal Laboratories Hydroxycarbamide Sales Market Share in 2017
Figure Global Khandelwal Laboratories Hydroxycarbamide Revenue Market Share in 2017
Table Alkem (Cytomed)
Table Alkem (Cytomed) Hydroxycarbamide
Table Samarth Pharma
Table Samarth Pharma Hydroxycarbamide
Table VHB Life Sciences
Table VHB Life Sciences Hydroxycarbamide
Table Global Hydroxycarbamide Sales by Manufacturer (2016-2017)
Figure Global Hydroxycarbamide Sales Market Share by Manufacturer in 2016
Figure Global Hydroxycarbamide Sales Market Share by Manufacturer in 2017
Table Global Hydroxycarbamide Revenue by Manufacturer (2016-2017)
Figure Global Hydroxycarbamide Revenue Market Share by Manufacturer in 2016
Figure Global Hydroxycarbamide Revenue Market Share by Manufacturer in 2017
Table Global Hydroxycarbamide Price by Manufacturer (2016-2017)
Figure Top 3 Hydroxycarbamide Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Hydroxycarbamide Manufacturer (Revenue) Market Share in 2017
Figure Global Hydroxycarbamide Sales and Growth Rate (2013-2018)
Figure Global Hydroxycarbamide Revenue and Growth Rate (2013-2018)
Table Global Hydroxycarbamide Sales by Regions (2013-2018)
Table Global Hydroxycarbamide Sales Market Share by Regions (2013-2018)
Table Global Hydroxycarbamide Revenue by Regions (2013-2018)
Figure Global Hydroxycarbamide Revenue Market Share by Regions in 2013
Figure Global Hydroxycarbamide Revenue Market Share by Regions in 2017
Figure North America Hydroxycarbamide Sales and Growth Rate (2013-2018)
Figure North America Hydroxycarbamide Revenue and Growth Rate (2013-2018)
Figure Europe Hydroxycarbamide Sales and Growth Rate (2013-2018)
Figure Europe Hydroxycarbamide Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Hydroxycarbamide Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hydroxycarbamide Revenue and Growth Rate (2013-2018)
Figure South America Hydroxycarbamide Sales and Growth Rate (2013-2018)
Figure South America Hydroxycarbamide Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Hydroxycarbamide Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hydroxycarbamide Revenue and Growth Rate (2013-2018)
Figure North America Hydroxycarbamide Revenue and Growth Rate (2013-2018)
Table North America Hydroxycarbamide Sales by Countries (2013-2018)
Table North America Hydroxycarbamide Sales Market Share by Countries (2013-2018)
Figure North America Hydroxycarbamide Sales Market Share by Countries in 2013
Figure North America Hydroxycarbamide Sales Market Share by Countries in 2017
Table North America Hydroxycarbamide Revenue by Countries (2013-2018)
Table North America Hydroxycarbamide Revenue Market Share by Countries (2013-2018)
Figure North America Hydroxycarbamide Revenue Market Share by Countries in 2013
Figure North America Hydroxycarbamide Revenue Market Share by Countries in 2017
Figure United States Hydroxycarbamide Sales and Growth Rate (2013-2018)
Figure Canada Hydroxycarbamide Sales and Growth Rate (2013-2018)
Figure Mexico Hydroxycarbamide Sales and Growth Rate (2013-2018)
Table North America Hydroxycarbamide Sales by Manufacturer (2016-2017)
Figure North America Hydroxycarbamide Sales Market Share by Manufacturer in 2016
Figure North America Hydroxycarbamide Sales Market Share by Manufacturer in 2017
Table North America Hydroxycarbamide Revenue by Manufacturer (2016-2017)
Figure North America Hydroxycarbamide Revenue Market Share by Manufacturer in 2016
Figure North America Hydroxycarbamide Revenue Market Share by Manufacturer in 2017
Table North America Hydroxycarbamide Sales by Type (2013-2018)
Table North America Hydroxycarbamide Sales Share by Type (2013-2018)
Table North America Hydroxycarbamide Revenue by Type (2013-2018)
Table North America Hydroxycarbamide Revenue Share by Type (2013-2018)
Table North America Hydroxycarbamide Sales by Application (2013-2018)
Table North America Hydroxycarbamide Sales Share by Application (2013-2018)
Table North America Hydroxycarbamide Revenue by Application (2013-2018)
Table North America Hydroxycarbamide Revenue Share by Application (2013-2018)
Figure Europe Hydroxycarbamide Revenue and Growth Rate (2013-2018)
Table Europe Hydroxycarbamide Sales by Countries (2013-2018)
Table Europe Hydroxycarbamide Sales Market Share by Countries (2013-2018)
Table Europe Hydroxycarbamide Revenue by Countries (2013-2018)
Figure Europe Hydroxycarbamide Revenue Market Share by Countries in 2016
Figure Europe Hydroxycarbamide Revenue Market Share by Countries in 2017
Figure Germany Hydroxycarbamide Sales and Growth Rate (2013-2018)
Figure UK Hydroxycarbamide Sales and Growth Rate (2013-2018)
Figure France Hydroxycarbamide Sales and Growth Rate (2013-2018)
Figure Russia Hydroxycarbamide Sales and Growth Rate (2013-2018)
Figure Italy Hydroxycarbamide Sales and Growth Rate (2013-2018)
Table Europe Hydroxycarbamide Sales by Manufacturer (2016-2017)
Figure Europe Hydroxycarbamide Sales Market Share by Manufacturer in 2016
Figure Europe Hydroxycarbamide Sales Market Share by Manufacturer in 2017
Table Europe Hydroxycarbamide Revenue by Manufacturer (2016-2017)
Figure Europe Hydroxycarbamide Revenue Market Share by Manufacturer in 2016
Figure Europe Hydroxycarbamide Revenue Market Share by Manufacturer in 2017
Table Europe Hydroxycarbamide Sales by Type (
  • Global Erlotinib Hydrochloride Market Insights, Forecast to 2025
    Published: 15-Aug-2018        Price: US 3900 Onwards        Pages: 99
    This report studies the global market size of Erlotinib Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Erlotinib Hydrochloride in these regions. This research report categorizes the global Erlotinib Hydrochloride market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, mark......
  • Global and India Cancer Treatment Drugs Market Research by Company, Type & Application 2013-2025
    Published: 15-Aug-2018        Price: US 2000 Onwards        Pages: 120
    Summary Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Market Segment as follows: By Type - Chemotherapy - Targeted Therapy - Immunotherapy (Biologic Therapy) - Hormonal Therapy - Others By Application - Blood Cancer - Breast Cancer - ......
  • Global Capecitabine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 134
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Capecitabine Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 135
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global and India Capecitabine Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 99
    Summary Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Market Segment as follows: By Type - 500 mg - 150 mg By Application - Breast Cancer - Colorectal cancer - Stomach Cancer ......
  • Global and India Mitomycin C Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 102
    Summary Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Market Segment as follows: By Type - 2 Mg - 10 Mg - 40 Mg - Others By Application - Cancer Trea......
  • Global and India Erlotinib Hydrochloride Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 122
    Summary Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells ......
  • 2018-2023 Global Cancer Treatment Drugs Consumption Market Report
    Published: 10-Aug-2018        Price: US 4660 Onwards        Pages: 179
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Cancer Treatment Drugs market for 2018-2023. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. The classification of cancer treatment drugs includes chemotherapy, targeted th......
  • Global Hydroxycarbamide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Aug-2018        Price: US 3480 Onwards        Pages: 137
    Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs